Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 08:48 ET | Source: BiomX

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

NETANYA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced the launch of X Security & Defense LTD., a new wholly-owned subsidiary. The company will...
March 26, 2026 08:45 ET | Source: Latin Metals Inc.

Latin Metals Commences First Systematic Exploration at Ventana North, within 500,000 Hectare Regional Copper Exploration Play, Northwest Argentina

Advancing a district-scale sediment-hosted copper belt in Argentina, targeting large-scale discovery potential across ~500,000 hectares.
March 26, 2026 08:36 ET | Source: Formula Systems (1985) Ltd.

Formula Systems Reports Fourth Quarter and Full Year 2025 Financial Results

PRESS RELEASE 2025 Full-year revenues increased by 18.4% year over year, reaching $2.63 billion. Net income attributable to Formula shareholders reached $606.5 million following the completion of...
March 26, 2026 08:30 ET | Source: Enlivex Ltd.

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

According to the Rain Foundation, anyone using OpenClaw or other AI agents can generate a live prediction market via a single prompt to the agent, without manual coding or centralized...
March 26, 2026 08:30 ET | Source: RenovoRx, Inc.

RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for...
March 26, 2026 08:30 ET | Source: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe – Advances Proposed Expedited...
March 26, 2026 08:30 ET | Source: Microbot Medical Inc.

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026 08:16 ET | Source: Leron X

Leron X Unveils Platform for Auto-posting, and Promotion on Twitter/X, Instagram, & More

LOS ANGELES, March 26, 2026 (GLOBE NEWSWIRE) -- Leron X has launched its platform focused on promoting contents, all in a single AI ecosystem. The AI content creation market is growing rapidly, but...
March 26, 2026 08:15 ET | Source: ZenaTech Inc.

ZenaTech to Present its Latest Drone Interceptors, Counter-UAS Defense System, ZenaDrone, and Zena AI Developments at Upcoming Investor Conferences and Industry Events

ZenaTech to Present its Latest Drone Interceptors, Counter-UAS Defense System, ZenaDrone, and Zena AI Developments at Upcoming Investor Conferences and In
March 26, 2026 08:05 ET | Source: MARA Holdings, Inc.

MARA Holdings, Inc. Announces $1.0 Billion Repurchase of 0.00% Convertible Senior Notes due 2030 and 2031 and Sale of 15,133 Bitcoin

Miami, FL, March 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a leading digital energy and infrastructure company, today announced that it has entered...